Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Targeted genomic analysis of cutaneous T cell lymphomas identifies a subset with aggressive clinicopathological features.
Argyropoulos KV, Pulitzer M, Maura F, Mohanty A, Mondello P, Horwitz SM, Myskowski P, Moskowitz A, Dogan A, Querfeld C, Rapaport F, Siakantaris M, Louis PC, Galasso N, van den Brink MRM, Palomba ML. Argyropoulos KV, et al. Among authors: horwitz sm. Blood Cancer J. 2020 Nov 9;10(11):116. doi: 10.1038/s41408-020-00380-5. Blood Cancer J. 2020. PMID: 33168809 Free PMC article. No abstract available.
Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.
Ekstrand BC, Lucas JB, Horwitz SM, Fan Z, Breslin S, Hoppe RT, Natkunam Y, Bartlett NL, Horning SJ. Ekstrand BC, et al. Among authors: horwitz sm. Blood. 2003 Jun 1;101(11):4285-9. doi: 10.1182/blood-2002-08-2644. Epub 2003 Feb 13. Blood. 2003. PMID: 12586628 Free article. Clinical Trial.
Rare T-cell lymphomas.
Molina AM, Horwitz SM. Molina AM, et al. Among authors: horwitz sm. Cancer Treat Res. 2008;142:331-47. doi: 10.1007/978-0-387-73744-7_14. Cancer Treat Res. 2008. PMID: 18283793 Review.
Novel therapies for cutaneous T-cell lymphomas.
Horwitz SM. Horwitz SM. Clin Lymphoma Myeloma. 2008 Dec;8 Suppl 5:S187-92. doi: 10.3816/CLM.2008.s.015. Clin Lymphoma Myeloma. 2008. PMID: 19073526 Review.
T-cell lymphomas.
Horwitz SM. Horwitz SM. Clin Adv Hematol Oncol. 2009 Jun;7(6):380-2. Clin Adv Hematol Oncol. 2009. PMID: 19606072 No abstract available.
Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
Moskowitz CH, Schöder H, Teruya-Feldstein J, Sima C, Iasonos A, Portlock CS, Straus D, Noy A, Palomba ML, O'Connor OA, Horwitz S, Weaver SA, Meikle JL, Filippa DA, Caravelli JF, Hamlin PA, Zelenetz AD. Moskowitz CH, et al. J Clin Oncol. 2010 Apr 10;28(11):1896-903. doi: 10.1200/JCO.2009.26.5942. Epub 2010 Mar 8. J Clin Oncol. 2010. PMID: 20212248 Free PMC article.
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.
Goldberg JD, Chou JF, Horwitz S, Teruya-Feldstein J, Barker JN, Boulad F, Castro-Malaspina H, Giralt S, Jakubowski AA, Koehne G, van den Brink MRM, Young JW, Zhang Z, Papadopoulos EB, Perales MA. Goldberg JD, et al. Leuk Lymphoma. 2012 Jun;53(6):1124-1129. doi: 10.3109/10428194.2011.645818. Epub 2012 Jan 31. Leuk Lymphoma. 2012. PMID: 22136377 Free PMC article.
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma.
Moskowitz CH, Matasar MJ, Zelenetz AD, Nimer SD, Gerecitano J, Hamlin P, Horwitz S, Moskowitz AJ, Noy A, Palomba L, Perales MA, Portlock C, Straus D, Maragulia JC, Schoder H, Yahalom J. Moskowitz CH, et al. Blood. 2012 Feb 16;119(7):1665-70. doi: 10.1182/blood-2011-10-388058. Epub 2011 Dec 19. Blood. 2012. PMID: 22184409 Free PMC article. Clinical Trial.
439 results